NASDAQ:ALLO

Allogene Therapeutics Stock Predictions

etoro logo Buy ALLO
*Your capital is at risk
$2.00
-0.0500 (-2.44%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

ALLO Prediction Chart

ALLO Predictions History

Latest community submissions for ALLO.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 18, 2025 $2.00 -2.16% $2.84 X 70.28% 0
Feb 18, 2025 Bearish $2.84 X 0
Mar 6, 2024 $5.26 -2.60% $5.63 X 93.42% 0
Mar 6, 2024 $5.31 -1.62% $5.63 X 94.36% 0
Mar 6, 2024 Bullish $5.63 V 1
JS JS Pro
Jun 21, 2022 $10.79 -1.55% $11.37 X 94.90% 0
Jun 21, 2022 Bullish $11.37 V 1
JS JS Pro
Dec 7, 2020 $34.15 +17.52% $29.06 X 82.48% 0
Mazie Paws Mazie Paws @MaziePaws.142718
Dec 7, 2020 $34.45 +18.55% $29.06 X 81.45% 0
sander7100 yo bro sander7100 yo bro Pro @sander7100yobro.167552
Aug 31, 2020 $34.68 -2.72% $35.65 X 97.28% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ALLO with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ALLOGENE THERAPEUTICS INC.
Allogene Therapeutics
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult patients with R/R CD19 positive B-cell ALL. The company also develops ALLO-501, an anti-CD19 allogeneic ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE